^
Association details:
Biomarker:No biomarker
Cancer:Maxillary Sinus Carcinoma
Regimen:VC (carboplatin + etoposide IV)
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
New
Source:
Excerpt:
Principles of systemic therapy for non-nasopharyngeal cancers: recurrent, unresectable, or metastatic (with no surgery or RT option)…useful in certain circumstances (first- and subsequent-line)…for select ethmoid/maxillary sinus cancers…cisplatin/etoposide or carboplatin/etoposide